US Stock MarketDetailed Quotes

STIM Neuronetics

Watchlist
  • 1.120
  • -0.040-3.45%
Close Dec 13 16:00 ET
  • 1.070
  • -0.050-4.46%
Post 20:01 ET
72.80MMarket Cap-0.92P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Dec 10 09:01
    NEWS
    $Neuronetics (STIM.US)$
    Neuronetics and Greenbrook TMS Announce Closing of Transaction
    Tuesday, 10th December at 10:00 am
    MALVERN, Pa. and TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTC: GBNHF) ("Greenbrook", and together with Neuronetics, the "Combined Company") today announced that they have successfully completed the previously announced transaction whereby Neuronetics acquired all of the issued and outstanding commo...
    Jaguar8
    Jaguar8
    Oct 14 07:31
    NEWS
    $Neuronetics (STIM.US)$
    NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
    Neuronetics, Inc. (NASDAQ: STIM) announced its participation at the American Academy of Child and Adolescent Psychiatry (AACAP) conference in Seattle, WA, from October 14th-19th. The company will present data on the NeuroStar TMS System in an oral presentation at the 'Research Pipeline: New Findings on Therapeutics' session. This presentation will ...
    Jaguar8
    Jaguar8
    Sep 25 07:33
    NEWS
    $Neuronetics (STIM.US)$
    Health Care Service Corporation Adds First-Line TMS Coverage for AdolescentsNeuronetics, Inc. (NASDAQ: STIM) announced that Health Care Service (HCSC) has expanded access to TMS (transcranial magnetic stimulation) for adolescents 15 and older with major depressive disorder (MDD). This policy update aligns with the recent FDA clearance of NeuroStar TMS Therapy as a first-line add-on treatment for this age group. HCSC, the largest customer-owned health insurer in the U.S...
    Trytosaveabit
    Trytosaveabit
    Sep 19 07:35
    News
    $Neuronetics (STIM.US)$ Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults
    3 MINUTES AGO, 8:31 AM EDT
    VIA GLOBENEWSWIRE
    MALVERN, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that additional payors have updated their TMS (transcranial magnetic stimulation) cove...
Read more
Heat List
US
Overall
Symbol
Price
% Chg

No Data